Compare OOMA & USBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OOMA | USBC |
|---|---|---|
| Founded | 2003 | N/A |
| Country | United States | |
| Employees | N/A | 6 |
| Industry | EDP Services | |
| Sector | Technology | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 343.1M | 333.2M |
| IPO Year | 2015 | N/A |
| Metric | OOMA | USBC |
|---|---|---|
| Price | $11.60 | $0.75 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $19.00 | N/A |
| AVG Volume (30 Days) | ★ 278.0K | N/A |
| Earning Date | 12-08-2025 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.08 | N/A |
| Revenue | ★ $264,115,000.00 | N/A |
| Revenue This Year | $6.45 | N/A |
| Revenue Next Year | $11.53 | N/A |
| P/E Ratio | $143.57 | ★ N/A |
| Revenue Growth | ★ 4.22 | N/A |
| 52 Week Low | $9.79 | N/A |
| 52 Week High | $15.65 | N/A |
| Indicator | OOMA | USBC |
|---|---|---|
| Relative Strength Index (RSI) | 51.41 | 47.07 |
| Support Level | $10.50 | $0.67 |
| Resistance Level | $12.04 | $0.91 |
| Average True Range (ATR) | 0.63 | 0.07 |
| MACD | 0.04 | -0.00 |
| Stochastic Oscillator | 47.83 | 35.55 |
Ooma Inc is a communications services company. It is a smart software-as-a-service (SaaS) and unified communications platform that deliver voice and collaboration features including messaging, intelligent virtual attendants and video conferencing, and residential phone service provides PureVoice high-definition voice quality, advanced functionality and integration with mobile devices. Its services rely upon the following main elements: multi-tenant cloud service, on-premise devices, desktop and mobile applications, and calling platforms. It generates revenues from the sale of subscriptions and other services.
USBC Inc is a non-invasive medical diagnostics. The group is focused on the development and commercialization of proprietary sensor technology utilizing radio and microwave dielectric spectroscopy. Its Sensor technology elicits a dielectric response that is different for every molecule. The group considers the business to currently have one operating segment: the development of its radio frequency spectroscopy technology, with a first focus on non-invasively ascertaining blood glucose levels.